德展健康：公司正在进行WYY注射剂型的IND申报准备

Core Viewpoint - Dezheng Health is actively developing an innovative drug project, WYY, aimed at treating stroke as a neuroprotective agent, with plans for IND application submission within the year [2] Group 1: Product Development - WYY is a self-developed innovative drug project by the company [2] - The company is preparing for the IND application for the WYY injection form and plans to submit it within the current year [2] - The company is also advancing research on the sublingual tablet form of WYY [2] Group 2: Regulatory Compliance - The company will fulfill disclosure obligations in accordance with regulatory requirements based on the progress of related matters [2]